If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Preference-weighted health-related quality of life measures and substance use disorder severity

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

ABSTRACT Aims 

Examine the validity of preference-weighted health-related quality of life measures in a sample of substance use disorder (SUD) patients. The implications of cost–utility analyses (CUAs) of SUD interventions are discussed. Design 

Cross-sectional analysis of subjects seeking SUD treatment. Setting 

Seven SUD treatment centers in a medium-sized Midwestern metropolitan area in the United States. Participants 

Data from 574 SUD subjects were analyzed from a study to test interventions to improve linkage and engagement with substance abuse treatment. Measurements 

Subjects completed the following preference-weighted measures: self-administered Quality of Well-Being scale (QWB-SA) and Medical Outcomes Study SF-12 (standard gamble weighted or SF-12 SG); and clinical measures: Addiction Severity Index (ASI) and a symptom checklist based on the DSM-IV. Findings 

In unadjusted analyses, the QWB-SA was correlated significantly with six of seven ASI subscales and the SF-12 SG was correlated with four of seven. In adjusted analyses, both preference-weighted measures were significantly correlated with diagnostic, physical health, mental health and drug use measures, but not with legal or alcohol use measures. The QWB-SA was also correlated with employment problems and the SF-12 SG was correlated with family/social problems. Conclusions 

This study generally supports the construct validity of preference-weighted health-related quality of life measures in SUD patients. However, the QWB-SA and SF-12 SG did not correlate with all ASI scales. Cost–benefit analysis may be preferable when policy-makers are interested in evaluating the full range of SUD intervention outcomes.

Keywords: Cost-effectiveness analysis; SF-12 scale; cost–utility analysis; health-related quality of life; quality of wellbeing scale; substance use disorder

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1360-0443.2008.02153.x

Affiliations: 1: Departments of Sociology, Economics and Epidemiology and Public Health, University of Miami, Miami, FL, USA and 2: Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA, 3: Department of Community Health, Wright State University, Dayton, OH, USA

Publication date: August 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more